If you need more lookups,
subscriptions start at $34 USD/month.
Ling Lin Location
Cambridge, MA, US
Ling Lin Work
Director of Clinical BioAnalytics and Translational Science @ (June 2023 - Present)
Associate Director of Clinical BioAnalytics and Translational Science @ (January 2022 - September 2023)
Senior Scientist II @ (May 2019 - February 2022)
Senior Scientist @ (March 2016 - May 2019)
Consultant @ (March 2016 - July 2016)
Scientist II, R and D group leader @ Dana-Farber Cancer Institute/ Harvard Medical School/ Broad Institute (May 2013 - March 2016)
Postdoctoral Fellow @ University of Massachusetts Medical School (January 2012 - January 2013)
Ling Lin Education
University of Massachusetts Medical School
Doctor of Philosophy (Ph.D.) (Biomedical Sciences)
2012
Harvard Business School Online 2020
Ling Lin Skills
Ex vivo and in vivo gene editing
PK/PD biomarkers
Ex vivo gene editing
in vivo gene editing
Drug Discovery
Translational Science
precision medicine
Pharmaceutical Industry
Biotechnology
Genetics
Cell Biology
Genomics
NGS
Molecular Diagnostics
Molecular & Cellular Biology
High Throughput Screening
Biomarker Discovery
Target Identification
Disease modeling
In vitro pharmacology
Science
Customer Service
Cell Culture
Assay Development
Technology Transfer
Recruiting
Life Sciences
Molecular Cloning
Molecular and Cellular Biology
Ling Lin Summary
Ling Lin, based in Cambridge, MA, US, is currently a Director of Clinical BioAnalytics and Translational Science at Beam Therapeutics. Ling Lin brings experience from previous roles at Beam Therapeutics, Beam Therapeutics Inc., Fulcrum Therapeutics and Third Rock Ventures. Ling Lin holds a Doctor of Philosophy (Ph.D.) in Biomedical Sciences @ University of Massachusetts Medical School. With a robust skill set that includes Ex vivo and in vivo gene editing, PK/PD biomarkers, Ex vivo gene editing, in vivo gene editing, Drug Discovery and more. Ling Lin has 2 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Ling Lin?
Find contact details for 700 million professionals.